Novel AI-Driven Infant Meningitis Screening from High Resolution Ultrasound Imaging - Sial, Hassan; Carandell, Francesc; Ajanovic, Sara; Jiménez, Javier; Quesada, Rita; Santos, Fabião; Buck, W. Chris; Sidat, Muhammad; UNITED Study Consortium; Bassat, Quique; Jobst, Beatrice; Petrone, Paula (medRxiv, 2024)
Background Infant meningitis can be a life-threatening disease and requires prompt and accurate diagnosis to prevent severe outcomes or death. Gold-standard diagnosis requires lumbar punctures (LP), to obtain and analyze cerebrospinal fluid (CSF). Despite being standard practice, LPs are invasive, pose risks for the patient and often yield negative results, either because of the contamination with red blood cells derived from the puncture itself, or due to the disease’s relatively low incidence due to the protocolized requirement to do LPs to discard a life-threatening infection in spite its relatively low incidence. Furthermore, in low-income settings, where the incidence is the highest, LPs and CSF exams are rarely feasible, and suspected meningitis cases are generally treated empirically. There’s a growing need for non-invasive, accurate diagnostic methods.Methodology We developed a three-stage deep learning framework using Neosonics® ultrasound technology for 30 infants with suspected meningitis and a permeable fontanelle, from three Spanish University Hospitals (2021-2023). In Stage 1, 2194 images were processed for quality control using a vessel/non-vessel model, with a focus on vessel identification and manual removal of images exhibiting artifacts such as poor coupling and clutter. This refinement process led to a focused cohort comprising 16 patients—6 cases (336 images) and 10 controls (445 images), yielding 781 images for the second stage. The second stage involved the use of a deep learning model to classify images based on WBC count threshold (set at 30 cells/mm3) into control or meningitis categories. The third stage integrated eXplainable Artificial Intelligence (XAI) methods, such as GradCAM visualizations, alongside image statistical analysis, to provide transparency and interpretability of the model’s decision-making process in our AI-driven screening tool.Results Our approach achieved 96% accuracy in quality control, 93% precision and 92% accuracy in image-level meningitis detection, and 94% overall patient-level accuracy. It identified 6 meningitis cases and 10 controls with 100% sensitivity and 90% specificity, demonstrating only a single misclassification. The use of GradCAM-based explainable AI (XAI) significantly enhanced diagnostic interpretability, and to further refine our insights, we incorporated a statistics-based XAI approach. By analyzing image metrics like entropy and standard deviation, we identified texture variations in the images, attributable to the presence of cells, which improved the interpretability of our diagnostic tool.Conclusion This study supports the efficacy of a multistage deep learning model for the non-invasive screening of infant meningitis and its potential to guide indications of LPs. It also highlights the transformative potential of AI in medical diagnostic screening for neonatal healthcare and paves the way for future research and innovations.Competing Interest StatementThe Biomedical Data Science Team at ISglobal receives training funding from Kriba.Funding StatementISGlobal acknowledges support from the grant CEX2018-000806-S funded by MCIN/AEI/ 10.13039/501100011033, support from the Generalitat de Catalunya through the CERCA Program, support from the Ministry of Research and Universities of the Government of Catalonia (2021 SGR 01563), support from the grant INV-048197 funded by the Bill and Melinda Gates Foundation, and from Instituto de Salud Carlos III (FIS PI16/00738). Kriba acknowledges support from the European Union's Horizon Europe research and innovation programme under project code 190155553 - NEOSONICS. CISM is supported by the Government of Mozambique and the Spanish Agency for International Development (AECID). Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:The Ethics Committee of Clinical investigation of the University Hospital La Paz (Madrid) gave ethical approval for this work (Approval reference number 5183)I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.YesAll data produced in the present study are available upon reasonable request to the authors